United States Ophthalmic Devices Medical Equipment Industry Report : Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Cataract Surgery, Refractive Surgery and Vision Care Equipment, Devices and Supplies

Table of Contents

Table of Contents

1 Table Of Contents 2
1.1 List Of Tables 11
1.2 List Of Figures 15
2 Introduction 18
2.1 What Is This Report About? 18
2.2 Definitions 18
2.2.1 Ophthalmic Devices 18
3 Healthcare Sector Review 20
3.1 Healthcare Expenditure 20
3.2 Healthcare Infrastructure 25
3.2.1 Healthcare Personnel Data 27
3.2.2 Healthcare Facilities Data 31
4 Opthalmic Devices in United states 33
4.1 Ophthalmic Devices Overall Revenues (2000-2012) 33
4.2 Opthalmic Devices Overall Volume (2000-2012) 39
4.3 Opthalmic Devices Overall Company Shares (2005-2006) 40
5 Vision Care in United States 42
5.1 Vision Care Overall Revenues (2000-2012) 42
5.1.1 Spectacles Overall Revenues (2000-2012) 46
5.1.2 Soft Contact Lenses Overall Revenues (2000-2012) 48
5.1.3 Lens Care Overall Revenues (2000-2012) 50
5.1.4 Opthalmoscope Overall Revenues (2000-2012) 52
5.1.5 Rigid Gas Permeable Contact Lenses Overall Revenues (2000-2012) 54
5.2 Vision Care Overall Volume (2000-2012) 56
5.2.1 Spectacles Overall Volume (2000-2012) 58
5.2.2 Soft Contact Lenses Overall Volume (2000-2012) 60
5.2.3 Lens Care Overall Volume (2000-2012) 62
5.2.4 Rigid Gas Permeable Contact Lenses Overall Volume (2000-2012) 64
5.2.5 Opthalmoscope Overall Volume (2000-2012) 66
5.3 Vision Care Average Price 68
5.3.1 Lens Care Average Price (2000-2012) 68
5.3.2 Opthalmoscope Average Price (2000-2012) 70
5.3.3 Rigid Gas Permeable Contact Lenses Average Price (2000-2012) 72
5.3.4 Soft Contact Lenses Average Price (2000-2012) 74
5.3.5 Spectacles Average Price (2000-2012) 76
5.4 Vision Care Distribution Share (2005-2006) 78
5.5 Vision Care Company Share (2005-2006) 79
6 Cataract Surgery in United States 81
6.1 Cataract Surgery Overall Revenues (2000-2012) 81
6.1.1 Phacoemulsification Equipment and Accessories Overall Revenues (2000-2012) 85
6.1.2 Intra Ocular Lens (IOL) Overall Revenues (2000-2012) 87
6.2 Cataract Surgery Overall Volume (2000-2012) 89
6.2.1 Intra Ocular Lens (IOL) Overall Volume (2000-2012) 90
6.2.2 Phacoemulsification Equipment and Accessories Overall Volume (2000-2012) 92
6.3 Cataract Surgery Average Price (2000-2012) 94
6.3.1 Intra Ocular Lens (IOL) Average Price (2000-2012) 94
6.3.2 Phacoemulsification Equipment and Accessories Averaga Price (2000-2012) 96
6.4 Cataract Surgery Distribution Share (2005-2006) 98
6.5 Cataract Surgery Company Share (2005-2006) 99
7 Refractive Surgery in United States 101
7.1 Refractive Surgery Overall Revenues (2000-2012) 101
7.1.1 Refractive Surgery Overall Revenues (2000-2012) 105
7.2 Refractive Surgery Overall Volume (2000-2012) 107
7.2.1 Refractive Surgery Overall Volume (2000-2012) 109
7.3 Refractive Surgery Average Price (2000-2012) 111
7.3.1 Refractive Surgery Average Price (2000-2012) 111
7.4 Refractive Surgery Distribution Share (2005-2006) 113
7.5 Refractive Surgery Company Share (2005-2006) 114
8 Johnson & Johnson Vision Care, Inc. Company Profile 115
8.1 Company Overview 115
8.2 Business Overview 115
8.2.1 Major Products and Services 115
8.2.2 History 116
8.3 Locations And Subsidiaries 116
8.4 Financial Deals Landscape 117
8.4.1 Essilor International Acquires The Spectacle Lens Group From Johnson & Johnson Vision Care 117
8.5 Recent Developments 118
8.5.1 Jan 07, 2008: Court of Appeals Upholds Verdicts in Favor of Cordis Corporation On Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation 118
9 Advanced Medical Optics, Inc. Company Profile 120
9.1 Company Overview 120
9.2 Business Overview 120
9.2.1 Cataract/Implant 120
9.2.2 Eye Care 121
9.2.3 Laser Vision Correction 121
9.2.4 Major Products and Services 122
9.2.5 History 122
9.3 123
9.4 Value Chain Analysis 124
9.4.1 Manufacturing 124
9.4.2 Product Development 124
9.4.3 Sales and Marketing 125
9.5 SWOT Analysis 125
9.5.1 Advanced Medical Optics, Inc. Strengths 126
9.5.2 Advanced Medical Optics, Inc. Weaknesses 126
9.5.3 Advanced Medical Optics, Inc. Opportunities 127
9.5.4 Advanced Medical Optics, Inc. Threats 127
9.6 Financial and Operational Review 129
9.6.1 Financial Statements 129
9.6.2 Financial Ratios 130
9.6.3 Share Holding Structure 131
9.7 Locations And Subsidiaries 131
9.8 Financial Deals Landscape 133
9.8.1 Advanced Medical Optics Signs An Agreement With Carl Zeiss Meditec 133
9.8.2 Advanced Medical Optics Acquires Intralase 134
9.8.3 Advanced Medical Optics Completes Private Placement Of $250 Million 136
9.8.4 Advanced Medical Optics Acquires Wavefront Sciences 137
9.8.5 Optobionics Secures $5 Million In Series D-1 Financing 139
9.8.6 Advanced Medical Optics Completes Private Placement Of $500 Million 141
9.8.7 Advanced Medical Optics Completes Private Placement Of $150 Million 143
9.8.8 Advanced Medical Optics Acquires VISX 144
9.8.9 Advanced Medical Optics Acquires Surgical Ophthalmology Business From Pfizer 146
9.8.10 Advanced Medical Optics Completes Private Placement Of $350 Million 148
9.8.11 Advanced Medical Optics Signs An Agreement With Quest Vision Technologies 150
9.8.12 Advanced Medical Optics to acquire Bausch & Lomb 151
9.9 Recent Developments 153
9.9.1 Feb 14, 2008: Advanced Medical Optics Reports Fourth-Quarter and Full-Year 2007 Results 153
9.9.2 Feb 14, 2008: Advanced Medical Declares Q4 2007 Results 155
9.9.3 Jan 21, 2008: Advanced Medical Optics Announces Release Date for Fourth Quarter and Full-Year 2007 Operating Results 158
9.9.4 Dec 05, 2007: AMO Elects Board Members 158
9.9.5 Nov 19, 2007: AMO Appoints New President 159
9.9.6 Oct 25, 2007: AMO Declares Q3 2007 Results 159
9.9.7 Oct 09, 2007: AMO Appoints CFO 161
9.9.8 Aug 02, 2007: AMO Declares Q2 2007 Results 161
9.9.9 Jul 23, 2007: AMO Set To Re-Enter Multipurpose Solution Market 163
9.9.10 Jun 26, 2007: AMO Revises Financial Guidance 2007 And 2008 163
9.9.11 May 22, 2007: AMO Adds New Board Member 164
9.9.12 Apr 25, 2007: AMO Declares Q1 2007 Results 164
9.9.13 Feb 13, 2007: AMO Declares Q4 2006 Results 166
9.9.14 Oct 26, 2006: AMO Declares Q3 2006 Results 168
9.9.15 Sep 25, 2006: AMO Lowers 2006 EPS, Revenue Guidance 169
9.9.16 Aug 01, 2006: AMO Declares Q2 2006 Results 169
9.9.17 Jun 08, 2006: AMO Increases 2006, 2007 EPS Guidance 171
9.9.18 May 25, 2006: AMO Appoints Chairman 171
9.10 Advanced Medical Optics, Inc. Pipeline Products 171
9.10.1 Sensar Hydrophobic Foldable Intraocular Lenses 171
9.10.2 Tecnis Multifocal intraocular lens 172
9.10.3 Presbyopic LASIK multi-focal 173
9.10.4 Quest accommodating intraocular lens 174
10 Bausch & Lomb Incorporated Company Profile 176
10.1 Company Overview 176
10.2 Business Overview 176
10.2.1 Cataract and Vitreoretinal Surgery Product Category 176
10.2.2 Contact Lenses Product Category 176
10.2.3 Lens Care Product Category 177
10.2.4 Pharmaceuticals Category 177
10.2.5 Refractive Surgery Product Category 178
10.2.6 Major Products and Services 178
10.2.7 History 179
10.3 Value Chain Analysis 180
10.3.1 Manufacturing 180
10.3.2 Product Development 181
10.3.3 Sales and Marketing 182
10.4 SWOT Analysis 182
10.4.1 Bausch & Lomb Incorporated Strengths 183
10.4.2 Bausch & Lomb Incorporated Weaknesses 183
10.4.3 Bausch & Lomb Incorporated Opportunities 184
10.4.4 Bausch & Lomb Incorporated Threats 184
10.5 Financial and Operational Review 185
10.5.1 Financial Statements 185
10.5.2 Financial Ratios 186
10.5.3 Share Holding Structure 187
10.6 Locations And Subsidiaries 188
10.7 Financial Deals Landscape 189
10.7.1 Bausch & Lomb Acquires eyeonics 189
10.7.2 Warburg Pincus Acquires Bausch & Lomb 190
10.7.3 Bausch & Lomb Completes Private Placement Of $650 Million 192
10.7.4 Bausch & Lomb Acquires Soothe Emollient (Lubricant) Eye Drops From Alimera Sciences 193
10.7.5 Bausch & Lomb Acquires Alimera' s OTC Eye Care Product 195
10.7.6 Bausch & Lomb Enters Into A Licensing Agreement With Schering AG 196
10.7.7 Bayer HealthCare Signs An Agreement With Bausch & Lomb 198
10.7.8 Bausch & Lomb Signs An Agreement With Cephalon 199
10.7.9 Bausch & Lomb Signs An Agreement With PTC Therapeutics 201
10.7.10 Bausch & Lomb Acquires Shandong Chia Tai Freda From Sino Biopharmaceutical 202
10.7.11 CIBA Vision And Bausch & Lomb Enter Into Cross-License Agreement 204
10.7.12 Advanced Medical Optics to acquire Bausch & Lomb 205
10.7.13 Bausch & Lomb Forms A Strategic Alliance With Acufocus 207
10.8 Recent Developments 209
10.8.1 Mar 06, 2008: Bausch & Lomb Appoints CVP, CHRO 209
10.8.2 Feb 05, 2008: J. Raymond Elliott and Richard F. Wallman Join Bausch & Lomb Board of Directors 209
10.8.3 Feb 05, 2008: Bausch & Lomb Appoints New Directors 210
10.8.4 Jan 23, 2008: Bausch & Lomb Appoints New CEO 210
10.8.5 Nov 20, 2007: Bausch & Lomb Appoints Corporate VP And General Counsel 211
10.8.6 Aug 08, 2007: Bausch & Lomb Reports Q2 2007 Results 211
10.8.7 Jul 24, 2007: Bausch & Lomb Declares Quarterly Dividend 212
10.8.8 Jun 26, 2007: Bausch & Lomb Files Suit Against Alcon 212
10.8.9 May 10, 2007: Bausch & Lomb Preliminary Q1 2007 Results 212
10.8.10 May 01, 2007: Bausch & Lomb Declares Quarterly Dividend 213
10.8.11 Mar 19, 2007: Bausch & Lomb Appoints New CFO 213
10.8.12 Mar 19, 2007: Bausch & Lomb CFO Retires 213
10.8.13 Mar 06, 2007: Bausch & Lomb Reports Preliminary Q4 And 2006 Results 213
10.8.14 Feb 26, 2007: Bausch & Lomb Declares Quarterly Dividend 214
10.8.15 Dec 22, 2006: Bausch & Lomb' s Listing On NYSE Extended 214
10.8.16 Nov 09, 2006: Bausch & Lomb Reports Preliminary Q3 2006 Results 214
10.8.17 Nov 07, 2006: Bausch & Lomb Declares Quarterly Dividend 216
10.8.18 Nov 06, 2006: Bausch & Lomb Receives FDA Warning Letter Related To Inspection At Greenville 216
10.8.19 Jul 25, 2006: Bausch & Lomb Declares Quarterly Dividend 216
10.8.20 May 02, 2006: Bausch & Lomb Declares Quarterly Dividend 216
10.8.21 Apr 19, 2006: Bausch & Lomb Names New President For Its Asia Region 216
10.9 Bausch & Lomb Incorporated Pipeline Products 217
10.9.1 Safarazi Elliptical Accommodating IOL 217
10.9.2 Akreos AO Micro-Incision sub--2-mm lens 217
11 Carl Zeiss Meditec AG Company Profile 219
11.1 Company Overview 219
11.2 Business Overview 219
11.2.1 Diagnosis 219
11.2.2 Laser and IOL 220
11.2.3 Service 220
11.2.4 Major Products and Services 221
11.3 Value Chain Analysis 222
11.3.1 Manufacturing 222
11.3.2 Product Development 223
11.3.3 Sales and Marketing 223
11.4 SWOT Analysis 224
11.4.1 Carl Zeiss Meditec AG Strengths 225
11.4.2 Carl Zeiss Meditec AG Weaknesses 225
11.4.3 Carl Zeiss Meditec AG Opportunities 226
11.4.4 Carl Zeiss Meditec AG Threats 226
11.5 Financial and Operational Review 228
11.5.1 Financial Statements 228
11.5.2 Financial Ratios 229
11.6 Locations And Subsidiaries 230
11.7 Financial Deals Landscape 232
11.7.1 Carl Zeiss Acquires Acri.Tec 232
11.7.2 Advanced Medical Optics Signs An Agreement With Carl Zeiss Meditec 233
11.7.3 Carl Zeiss Meditec Acquires 5% Shareholding In Wavelight 234
11.7.4 Carl Zeiss Meditec Acquires IOLTECH 235
11.7.5 Carl Zeiss Meditec And PULSION Medical Systems Enter Into Licensing Agreement 237
11.8 Recent Developments 238
11.8.1 Mar 27, 2008: Grand Opening: Carl Zeiss opens S$30 million demo facility to boost Singapore' s R&D excellence 238
11.8.2 Jan 22, 2008: New Sales Manager: Reorganization of Sales at Carl Zeiss Sports Optics 240
11.8.3 Oct 08, 2007: CZM Appoints New Board Member 240
11.8.4 Aug 23, 2007: CZM Announces Supervisory Board Changes 240
11.8.5 Aug 08, 2007: CZM First Nine Months 2007 Results 241
11.8.6 Mar 01, 2007: CZM Reports Fiscal 2005/06 Results 242
11.8.7 Feb 14, 2007: CZM Reports Q1 2006/07 Results 243
11.8.8 Nov 13, 2006: CZM Lawsuit with IntraLase 245
11.8.9 Oct 13, 2006: CZM Wins Against Complainants In Court 245
11.8.10 Sep 11, 2006: CZM Appoints Executive Board Member 246
11.9 Carl Zeiss Meditec AG Pipeline Products 247
11.9.1 IOL Master 247
11.9.2 VISULAS 690 PLUS 247
11.9.3 Multifocal IOL 248
11.9.4 New laser system 248
11.9.5 VisuCAm platform(New applications) 249
12 CIBA Vision Corporation Company Profile 250
12.1 Company Overview 250
12.2 Business Overview 250
12.2.1 Major Products and Services 251
12.2.2 History 251
12.3 Locations And Subsidiaries 252
12.4 Financial Deals Landscape 254
12.4.1 CIBA Vision And CooperVision Enter Into A Licensing Agreement 254
12.4.2 CIBA Vision And Bausch & Lomb Enter Into Cross-License Agreement 255
12.4.3 CIBA Vision Sells Its Surgical Business To IOLTECH 256
12.4.4 CIBA Vision Signs An Agreement With Optonol 258
12.5 Recent Developments 259
12.5.1 Nov 21, 2007: CIBA Vision Settles Patent Litigation With CooperVision 259
12.5.2 Feb 21, 2006: CIBA Vision Appoints New CEO 260
12.5.3 Apr 02, 2004: CIBA Vision Appoints New Finance Officer 260
12.5.4 Apr 02, 2004: CIBA Vision Appoints New President 260
12.6 CIBA Vision Corporation Pipeline Products 260
12.6.1 Non-Moulded Soft Contact Lenses 260
13 Regulation System 263
13.1 Medical Equipment Approval Process 263
13.1.1 Pre-market Approval Process 264
13.1.2 Intended use and Indications for use 264
13.1.3 Predicate Device 264
13.1.4 Safe and Effective 265
13.1.5 Other Category Devices 267
13.1.6 Post-Market Approval Process 268
13.1.7 Compliance and Enforcement 268
13.1.8 Registration Fee 269
13.1.9 Approval Time 269
14 Pricing and Reimbursement 270
14.1 Government Policies 270
14.2 Private Insurance 271
14.3 Diagnosis Related Groups (DRG) 272
15 Distribution Structure 273
15.1 Distribution Structure 273
16 APPENDIX 274
16.1 Global Markets Direct Research Methodology 274
16.2 Coverage 275
16.3 Secondary Research 275
16.4 Primary Research 276
16.5 Models 276
16.6 Forecasts 277
16.7 Expert Panels 277
16.8 Contact Us 278
16.9 Disclaimer 278